Ukujova komzimba: funda ukuthi i-immunotherapy ethile isebenza kanjani

-Delile

• Ngabe i-immunotherapy ethize iqukethe ini?
• Ngubani ongenza ukwelashwa
• Ngubani ongafanele ukwelashwa

I-immunotherapy ethize iqukethe ukujova imijovo yokungezwani komzimba, ngemithamo ekhulayo, ukunciphisa ubuzwe bomuntu ongezwani nalezi zilwelwe.

Ukungezwani komzimba wukusabela okweqile kohlelo lokuzivikela komzimba lapho umzimba uvezwa entweni oqonda ukuthi ingumuthi oyingozi. Kungenxa yalesi sizathu abanye abantu beguliswa yiboya bezilwane noma bezibungu, ngokwesibonelo, kanti abanye akunjalo. Abantu okungenzeka ukuthi bahlushwa ukungezwani komzimba nalabo abanezifo zokuphefumula ezifana nesifuba somoya, i-rhinitis noma i-sinusitis.

Ngakho-ke, i-immunotherapy ethize iyindlela enhle yokwelashwa kubantu abanezifo ezifana ne-allergen rhinitis, i-conjunctivitis yokungezwani komzimba, i-asthma yokungezwani komzimba, ukungezwani komzimba ne-bite yokulunywa yizinambuzane noma ezinye izifo ze-IgE-mediated hypersensitivity.

Ngabe i-immunotherapy ethize iqukethe ini?

Umuthi wokugomela komzimba kumele ukhiqizelwe umuntu ngamunye, ngamunye. Ingasetshenziswa njengomjovo noma njengamaconsi ngaphansi kolimi futhi iqukethe inani elikhulayo le-allergen.

Ama-allergen okufanele asetshenziswe ekwelashweni okuthile kwe-immunotherapy kufanele akhethwe ngokuya ngezivivinyo zomzimba, ezivumela ukuhlolwa kwekhwalithi nokulinganisa komzimba. Udokotela anga-oda izivivinyo ezifana ne-allergen test reaction yesikhumba, ukuhlolwa kwegazi okubizwa nge-REST noma i-Immunocap ukuthola kahle ukuthi iziphi izixazululo zalowo muntu. Thola ukuthi lokhu kuhlolwa kwenziwa kanjani.

Umthamo wokuqala kufanele uvumelaniswe nokuzwela komuntu bese kuthi amanani kufanele akhuliswe ngokuqhubekayo futhi alawulwe ngezikhathi ezithile, kuze kufinyelelwe umthamo wesondlo.

Isikhathi sokwelashwa singahluka kusuka komunye umuntu kuya komunye, ngoba ukwelashwa kukhethiwe. Le mijovo ivame ukubekezelelwa kahle futhi ayivezi imiphumela emibi emibi, futhi kwezinye izimo ukuqubuka kwesikhumba nokubomvu kungenzeka.

Ngubani ongenza ukwelashwa

I-Immunotherapy ikhonjiswa kubantu abahlushwa ukwelashwa okweqile okungalawulwa. Abantu abakhonjiswe kakhulu ukwenza lolu hlobo lokwelashwa yilabo abanenkinga yokuphefumula efana nesifuba somoya, i-allergen rhinitis, i-allergen conjunctivitis, i-latex yokungezwani komzimba, ukungezwani kokudla noma ukusabela kokulunywa yizinambuzane, isibonelo.

Ngubani ongafanele ukwelashwa

Ukwelashwa akufanele kwenziwe kubantu abane-asthma encike ku-corticosteroid, i-atopic dermatitis enamandla, abesifazane abakhulelwe, asebekhulile abangaphansi kweminyaka engu-2 kanye nabantu abadala.

Ngaphezu kwalokho, akuphakanyiswa futhi kubantu abanezifo ezizimele, ukuphazamiseka okukhulu kwengqondo, abasebenzisa i-adrenergic beta-blockers, abanezifo ezingezona ze-IgE-mediated izifo kanye nezimo ezinobungozi zokusetshenziswa kwe-epinephrine.

Ukusabela okungalungile okungenzeka

Eminye yemiphumela engenzeka ngesikhathi sokwelashwa kwe-immunotherapy, ikakhulukazi imizuzu engama-30 ngemuva kokuthola imijovo yi-erythema, ukuvuvukala nokunwaya endaweni yomjovo, ukuthimula, ukukhwehlela, ukusabalalisa i-erythema, isifuba nokuphefumula kanzima.